kinetin has been researched along with bohemine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (87.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gouldsworthy, A; Hajdúch, M; Halada, P; Korínková, G; Kovárová, H; Krupicková, S; Strnad, M; Zhelev, N | 1 |
Hajdúch, M; Hlobilková, A; Kolár, Z; Lenobel, R; Lukesová, M; Mad'arová, J; Murray, PG; Perera, S; Strnad, M; Vojtesek, B | 1 |
Bartos, J; Kylarová, D; Lichnovský, V; Mad'arová, J; Procházková, J | 1 |
Dolezal, K; Malon, M; Marek, J; Strnad, M; Trávnícek, Z; Zatloukal, M | 1 |
Barrie, SE; Brunton, L; Clarke, SJ; Eccles, S; Fischer, PM; Garrett, MD; Kelland, LR; Lane, DP; McClue, S; Raynaud, FI; Rogers, P; Valenti, M; Walton, MI; Whittaker, SR; Workman, P | 1 |
Krystof, V; Sipl, M; Trávnícek, Z | 1 |
An, R; Hagiya, Y; Ishikawa, T; Li, S; Saito, H; Tamura, A; Tokushima, D | 1 |
Cwiertka, K; Dzubak, P; Hajduch, M; Korinkova, G; Paprskarova, M | 1 |
8 other study(ies) available for kinetin and bohemine
Article | Year |
---|---|
Proteomics approach in classifying the biochemical basis of the anticancer activity of the new olomoucine-derived synthetic cyclin-dependent kinase inhibitor, bohemine.
Topics: Antineoplastic Agents; Cyclin-Dependent Kinases; Electrophoresis, Gel, Two-Dimensional; Enzyme Inhibitors; Humans; Kinetin; Neoplasm Proteins; Proteome; Purines; Tumor Cells, Cultured | 2000 |
Synthetic inhibitors of CDKs induce different responses in androgen sensitive and androgen insensitive prostatic cancer cell lines.
Topics: Cell Division; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Kinetin; Male; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Purines; Receptors, Androgen; Tumor Cells, Cultured | 2002 |
Comparison of the TUNEL, lamin B and annexin V methods for the detection of apoptosis by flow cytometry.
Topics: Annexin A5; Apoptosis; Dactinomycin; DNA Fragmentation; Enzyme Inhibitors; Etoposide; Flow Cytometry; Fluorescent Antibody Technique, Indirect; HL-60 Cells; Humans; In Situ Nick-End Labeling; Kinetin; Lamin Type B; Purines; Sensitivity and Specificity | 2002 |
Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl(3)].9/5H2O [Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine].
Topics: Antineoplastic Agents; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Kinetin; Ligands; Magnetic Resonance Spectroscopy; Models, Molecular; Organometallic Compounds; Organoplatinum Compounds; Palladium; Platinum; Purines; Structure-Activity Relationship; Tumor Cells, Cultured | 2003 |
In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine, bohemine and CYC202.
Topics: Animals; Area Under Curve; Blotting, Western; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinases; Enzyme Inhibitors; Female; HCT116 Cells; Humans; Inhibitory Concentration 50; Kinetin; Maximum Tolerated Dose; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; Phosphorylation; Purines; Recombinant Proteins; Retinoblastoma Protein; Roscovitine; Time Factors; Tissue Distribution; Xenograft Model Antitumor Assays | 2005 |
Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity.
Topics: Antineoplastic Agents; Benzyl Compounds; Cell Line, Tumor; Chlorides; Crystallography, X-Ray; Cyclin-Dependent Kinases; Differential Thermal Analysis; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Kinetin; Ligands; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Organometallic Compounds; Purines; Spectrophotometry, Infrared; Zinc Compounds | 2006 |
Cellular phototoxicity evoked through the inhibition of human ABC transporter ABCG2 by cyclin-dependent kinase inhibitors in vitro.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Cell Survival; Chlorophyll; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Hematoporphyrins; Humans; Kinetin; Models, Molecular; Molecular Conformation; Molecular Structure; Neoplasm Proteins; Photosensitizing Agents; Protein Kinase Inhibitors; Purines; Quantitative Structure-Activity Relationship; Quinazolines; Roscovitine; Spodoptera; Transfection | 2009 |
The radiosensitising effect of olomoucine derived synthetic cyclin-dependent kinase inhibitors.
Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Cell Cycle; Cyclin-Dependent Kinases; Flow Cytometry; Humans; Kinetin; Lung Neoplasms; Protein Kinase Inhibitors; Purines; Radiation-Sensitizing Agents; Roscovitine; Tumor Cells, Cultured; X-Rays | 2010 |